[{"id":"3aab748d-9769-4407-bd7c-6604140f23ce","acronym":"","url":"https://clinicaltrials.gov/study/NCT03556566","created_at":"2021-01-18T17:30:22.884Z","updated_at":"2024-07-02T16:36:56.089Z","phase":"Phase 2","brief_title":"Open Label Immunotherapy Trial for Ovarian Cancer","source_id_and_acronym":"NCT03556566","lead_sponsor":"Immunitor LLC","biomarkers":" MUC16","pipe":"","alterations":" ","tags":["MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e V3-OVA"],"overall_status":"Unknown status","enrollment":" Enrollment 20","initiation":"Initiation: 07/01/2018","start_date":" 07/01/2018","primary_txt":" Primary completion: 11/30/2019","primary_completion_date":" 11/30/2019","study_txt":" Completion: 12/31/2019","study_completion_date":" 12/31/2019","last_update_posted":"2019-08-30"}]